0
     

LATEST REPORT

View all
Research Report on China's Escitalopram Market, 2021-2025

Research Report on China's Escitalopram Market, 2021-2025

Depression is the fourth leading disease in the world and is expected to become the first by 2030. However, the medical prevention and treatment of depression in China is still of low recognition rate, which is less than 20% of Chinese hospitals at all levels. Moreover, less than 20% of Chinese patients suffering from...

Research Report on China's Gefitinib Market, 2021-2025

Research Report on China's Gefitinib Market, 2021-...

Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 19.29 million new cancer cases wer...

Research Report on China's Levetiracetam Market, 2021-2025

Research Report on China's Levetiracetam Market, 2...

Epilepsy is second only to stroke as a common chronic neurological disorder characterized by excessive neuronal discharg...

Research Report on China's Zoledronic Acid Market, 2021-2025

Research Report on China's Zoledronic Acid Market,...

Osteoporosis is a metabolic disease caused by a combination of endocrine, nutritional, immune, and genetic factors, and...

Research Report on China's Dabigatran Etexilate Market, 2021-2025

Research Report on China's Dabigatran Etexilate Ma...

Dabigatran Etexilate is an oral anticoagulant drug used for the prevention of thrombus and embolus formation after major...

Research Report on China's Mesalazine Market, 2021-2025

Research Report on China's Mesalazine Market, 2021...

Inflammatory bowel disease (IBD) is a chronic disease of the digestive system with unclear etiology, difficulty to cure,...

Research Report on China's Exemestane Market, 2021-2025

Research Report on China's Exemestane Market, 2021...

Breast cancer is a common malignant tumor in menopausal women, and now ranks first among malignant tumors in women. Rece...